{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2022:IDTFXWXWPMEOBPZIRCDODNQL27","short_pith_number":"pith:IDTFXWXW","canonical_record":{"source":{"id":"2206.09669","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.AP","submitted_at":"2022-06-20T09:19:05Z","cross_cats_sorted":["stat.ME"],"title_canon_sha256":"633af2647bf730eabac75a0a5bb8bc20c47cec4828b123ba738256492ba22f1a","abstract_canon_sha256":"55996a7d426e4d683a64eaf4659418dfe565f015604a680c979bf865a4878098"},"schema_version":"1.0"},"canonical_sha256":"40e65bdaf67b08e0bf288886e1b60bd7eef38e87544b2663ad31140be6540215","source":{"kind":"arxiv","id":"2206.09669","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2206.09669","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"arxiv_version","alias_value":"2206.09669v1","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2206.09669","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"pith_short_12","alias_value":"IDTFXWXWPMEO","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"pith_short_16","alias_value":"IDTFXWXWPMEOBPZI","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"pith_short_8","alias_value":"IDTFXWXW","created_at":"2026-07-05T04:33:09Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2022:IDTFXWXWPMEOBPZIRCDODNQL27","target":"record","payload":{"canonical_record":{"source":{"id":"2206.09669","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.AP","submitted_at":"2022-06-20T09:19:05Z","cross_cats_sorted":["stat.ME"],"title_canon_sha256":"633af2647bf730eabac75a0a5bb8bc20c47cec4828b123ba738256492ba22f1a","abstract_canon_sha256":"55996a7d426e4d683a64eaf4659418dfe565f015604a680c979bf865a4878098"},"schema_version":"1.0"},"canonical_sha256":"40e65bdaf67b08e0bf288886e1b60bd7eef38e87544b2663ad31140be6540215","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T04:33:09.685709Z","signature_b64":"VhHyEzGB+9GXmZT5CxBz5wt76d9WLw6tgNe46QTRRRuTAH6Ze39tW7xfdK8pt2T3dMdHvA1Y5PItJ1eltkT3AQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"40e65bdaf67b08e0bf288886e1b60bd7eef38e87544b2663ad31140be6540215","last_reissued_at":"2026-07-05T04:33:09.685217Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T04:33:09.685217Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2206.09669","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T04:33:09Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"w1kvsYZ2HYqS24BZF2W6POM4Q+5WtUSVvUtZRN/g/AYscI9DgdCdTJPtCjWto0AnlejRkQc+1u9jo+ncZegJAA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-04T22:57:18.382595Z"},"content_sha256":"8590405d4d21c6a2921fe590ca80267d74c832fff8f2a7c679564b3066cb845e","schema_version":"1.0","event_id":"sha256:8590405d4d21c6a2921fe590ca80267d74c832fff8f2a7c679564b3066cb845e"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2022:IDTFXWXWPMEOBPZIRCDODNQL27","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"How to improve the quality of comparisons using external control cohorts in single-arm clinical trials?","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"","cross_cats":["stat.ME"],"primary_cat":"stat.AP","authors_text":"Etienne Lengline, J\\'er\\^ome Lambert, Rapha\\\"el Porcher, Rodolphe Thi\\'ebaut, Sarah Zohar, Sylvie Chevret","submitted_at":"2022-06-20T09:19:05Z","abstract_excerpt":"PURPOSE Providing rapid answers and early acces to patients to innovative treatments without randomized clinical trial (RCT) is growing, with benefit estimated from single-arm trials. This has become common in oncology, impacting the approval pathway of health technology assessment agencies. We aimed to provide some guidance for indirect comparison to external controls to improve the level of evidence following such uncontrolled designs. METHODS We used the illustrative example of blinatumomab, a bispecific antibody for the treatment of B-cell ALL in complete remission (CR) with persistent min"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2206.09669","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2206.09669/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T04:33:09Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"BuhaWxU8URGZ3LxIZPBIM2yK2A9vP05iM096oyEBd7LRts+dSesUbDgPJa8GdEIBoJ0pJanj9k8lEl7Im6Q7Aw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-04T22:57:18.383201Z"},"content_sha256":"584c5f11c2e0cda41d1d943ef354167febe5354ff27bdaf252190d24b95f2694","schema_version":"1.0","event_id":"sha256:584c5f11c2e0cda41d1d943ef354167febe5354ff27bdaf252190d24b95f2694"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/IDTFXWXWPMEOBPZIRCDODNQL27/bundle.json","state_url":"https://pith.science/pith/IDTFXWXWPMEOBPZIRCDODNQL27/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/IDTFXWXWPMEOBPZIRCDODNQL27/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-04T22:57:18Z","links":{"resolver":"https://pith.science/pith/IDTFXWXWPMEOBPZIRCDODNQL27","bundle":"https://pith.science/pith/IDTFXWXWPMEOBPZIRCDODNQL27/bundle.json","state":"https://pith.science/pith/IDTFXWXWPMEOBPZIRCDODNQL27/state.json","well_known_bundle":"https://pith.science/.well-known/pith/IDTFXWXWPMEOBPZIRCDODNQL27/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2022:IDTFXWXWPMEOBPZIRCDODNQL27","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"55996a7d426e4d683a64eaf4659418dfe565f015604a680c979bf865a4878098","cross_cats_sorted":["stat.ME"],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.AP","submitted_at":"2022-06-20T09:19:05Z","title_canon_sha256":"633af2647bf730eabac75a0a5bb8bc20c47cec4828b123ba738256492ba22f1a"},"schema_version":"1.0","source":{"id":"2206.09669","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2206.09669","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"arxiv_version","alias_value":"2206.09669v1","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2206.09669","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"pith_short_12","alias_value":"IDTFXWXWPMEO","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"pith_short_16","alias_value":"IDTFXWXWPMEOBPZI","created_at":"2026-07-05T04:33:09Z"},{"alias_kind":"pith_short_8","alias_value":"IDTFXWXW","created_at":"2026-07-05T04:33:09Z"}],"graph_snapshots":[{"event_id":"sha256:584c5f11c2e0cda41d1d943ef354167febe5354ff27bdaf252190d24b95f2694","target":"graph","created_at":"2026-07-05T04:33:09Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2206.09669/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"PURPOSE Providing rapid answers and early acces to patients to innovative treatments without randomized clinical trial (RCT) is growing, with benefit estimated from single-arm trials. This has become common in oncology, impacting the approval pathway of health technology assessment agencies. We aimed to provide some guidance for indirect comparison to external controls to improve the level of evidence following such uncontrolled designs. METHODS We used the illustrative example of blinatumomab, a bispecific antibody for the treatment of B-cell ALL in complete remission (CR) with persistent min","authors_text":"Etienne Lengline, J\\'er\\^ome Lambert, Rapha\\\"el Porcher, Rodolphe Thi\\'ebaut, Sarah Zohar, Sylvie Chevret","cross_cats":["stat.ME"],"headline":"","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.AP","submitted_at":"2022-06-20T09:19:05Z","title":"How to improve the quality of comparisons using external control cohorts in single-arm clinical trials?"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2206.09669","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:8590405d4d21c6a2921fe590ca80267d74c832fff8f2a7c679564b3066cb845e","target":"record","created_at":"2026-07-05T04:33:09Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"55996a7d426e4d683a64eaf4659418dfe565f015604a680c979bf865a4878098","cross_cats_sorted":["stat.ME"],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.AP","submitted_at":"2022-06-20T09:19:05Z","title_canon_sha256":"633af2647bf730eabac75a0a5bb8bc20c47cec4828b123ba738256492ba22f1a"},"schema_version":"1.0","source":{"id":"2206.09669","kind":"arxiv","version":1}},"canonical_sha256":"40e65bdaf67b08e0bf288886e1b60bd7eef38e87544b2663ad31140be6540215","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"40e65bdaf67b08e0bf288886e1b60bd7eef38e87544b2663ad31140be6540215","first_computed_at":"2026-07-05T04:33:09.685217Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T04:33:09.685217Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"VhHyEzGB+9GXmZT5CxBz5wt76d9WLw6tgNe46QTRRRuTAH6Ze39tW7xfdK8pt2T3dMdHvA1Y5PItJ1eltkT3AQ==","signature_status":"signed_v1","signed_at":"2026-07-05T04:33:09.685709Z","signed_message":"canonical_sha256_bytes"},"source_id":"2206.09669","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:8590405d4d21c6a2921fe590ca80267d74c832fff8f2a7c679564b3066cb845e","sha256:584c5f11c2e0cda41d1d943ef354167febe5354ff27bdaf252190d24b95f2694"],"state_sha256":"646ef062c7b5e450230cda056b348ffb421c833fb629b3711e66bdc8985949ae"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"+ui98PdD7Jpg3RI/BCsGfGfLNF694wARnXp/DxAPMKQeChe+eZ76LvyNrCH5fMoHCuUF8Y1rMK6tcizLxupYDg==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-04T22:57:18.388939Z","bundle_sha256":"8aa9ae4992a38982f520dd07827f7bdaec67a3363f3ef31dd747739b0b5c33af"}}